Sean O'Donnell

Sean O'Donnell

McDermott Will & Emery

Contact  |  View Bio  |  RSS

Latest Publications

Share:

What Is “a Patient?”

Braintree Labs, Inc. v. Novel Labs, Inc. - On appeal from summary judgment, the U.S. Court of Appeals for the Federal Circuit construed “a patient” to mean “a population of patients,” overturning the district court’s...more

6/5/2014 - ANDA Appeals Generic Drugs Patent Infringement Patent Litigation Patents Patients Pharmaceutical Pharmaceutical Patents

Combining Two Drugs Is Not Always Obvious

Sanofi-Aventis Deutschland GMBH v. Glenmark Pharmaceuticals Inc. - Addressing the obviousness of combining two known hypertension medications, the U.S. Court of Appeals for the Federal Circuit upheld a ruling of...more

6/3/2014 - Appeals FDA License Agreements Obviousness Patent Infringement Patent Litigation Patents Pharmaceutical Pharmaceutical Patents Prescription Drugs Prior Art

The Explicit Definition of a Claim Term Is Not Limiting Where It Excludes a Preferred Embodiment - ButamaxTM Advanced Biofuels,...

Relying in part on evidence that a district court’s claim construction excluded a preferred embodiment, which was the subject of a dependent claim, the U.S. Court of Appeals for the Federal Circuit explained that the...more

3/28/2014 - Biofuel Claim Construction Patent Litigation Patents

Narrower of Possible Claim Constructions Prevails - Takeda Pharmaceutical Co. Ltd. v. Zydus Pharma USA, Inc.

Addressing, among other things, where the upper limit of a claimed range lies for claim construction, the U.S. Court of Appeals for the Federal Circuit overturned a district court ruling that a claimed range included a margin...more

3/28/2014 - Claim Construction Patent Infringement Patent Litigation Patents Pharmaceutical

4 Results
|
View per page
Page: of 1